WTB (What the Bug?)
The primary organism responsible for erysipelas.
Group A Streptococci (S. pyogenes)
Risk factors for infection with HA-MRSA.
Recent antibiotic treatment, healthcare system exposure
The organism that antibiotic therapy should be directed against with a moderate purulent skin infection.
CA-MRSA
The lay press term for Streptococcus pyogenes.
"Flesh-eating" bacteria
The patient population where this infection is most commonly observed.
Pediatrics
The organism that displays Panton-Valentine leucocidin (PVL).
CA-MRSA
Classification of bacterial infection following invasion of healthy skin.
Primary/monomicrobial
The organism(s) that antibiotic therapy should be targeted against for an animal bite wound.
Pasteurella spp.
The organism associated with myonecrosis in necrotizing fasciitis.
Clostridioides perfringes
The primary organism responsible for bullous manifestations.
Toxin-producing Staphylococcus aureus
The primary organism responsible for necrotizing fasciititis.
Group A Streptococci (S. pyogenes)
These three factors contribute to infections caused by CA-MRSA.
Playing contact sports, daycare attendance, living in close quarters
The preferred antibiotic for outpatient treatment of a mild, non-purulent skin infection.
Penicillin-VK
The name of a clinical feature that causes a crackling sound upon skin palpation.
Crepitus
Empiric treatment for localized infection.
Topical treatment with mupirocin or retapamulin
The organism(s) most likely to be responsible for infection following a human bite wound.
Eikenella corrodens, Staphylococci
These six risk factors can predispose to development of SSTIs.
high bacterial concentration, excessive skin moisture, poor blood supply, bacterial nutrients, damage to corneal layer, immune suppression
The antibiotics preferred for inpatient treatment of methicillin-susceptible S. aureus (MSSA) infection.
Criteria for tetanus vaccination following an animal bite.
Recommended therapy when systemic manifestations or multiple lesions are present.
SMX/TMP, doxycycline, or clindamycin
Colonization of the nares with this organism can result in recurrent skin infections.
Staphylococcus aureus (MRSA)
Intravenous drug use is a risk factor for infection with these organisms.
MRSA, P. aeruginosa
The preferred antibiotic for empiric inpatient treatment of bite wounds.
The antibiotics that can be given in 1-2 doses to complete a treatment course and are best reserved for outpatient treatment of cellulitis following hospitalization.
Dalbavancin, oritavancin
The physical appearance of skin lesions.